Molecular Signatures Are Redefining Cancer Treatment
New studies demonstrate that treating cancer based on its molecular vulnerabilities, rather than where it originated, could translate to better outcomes for patients
New studies demonstrate that treating cancer based on its molecular vulnerabilities, rather than where it originated, could translate to better outcomes for patients
Plastics have yielded life-saving medical advances, supercharged technological advancements, helped send us to space, and transformed our lives in innumerable ways. But they are poisoning our people and our planet.
With a new genome sequence, more diverse data sets, and population-specific projects, scientists are making progress in representing humanity’s real DNA diversity.
Millions of people with weakened immune systems are poorly protected against Covid by current vaccines. Scientists in Germany have developed a new vaccine intended especially for them.
CAR T therapies juice the immune system. In cancer, they have cured patients who had little hope for survival. Now scientists are asking "What else can they do?"
It’s time to overhaul the chemical industry — for the sake of fenceline communities and the rest of the planet.
Scientists in Ontario used machine learning techniques to find telltale signs of cancer in blood samples that were collected up to seven years prior to conventional diagnosis.
By looking at cancer as an engineering problem instead of a medical one, scientists are homing in on vulnerabilities that may lead to new ways to knock out tumors.
Understanding how an old person’s disease develops in kids could offer clues about how to predict, or maybe even prevent, pediatric cancers.